CRISPR-Cas9 | Australian Biotech Company News

Home Tags CRISPR-Cas9

Biotechnology

Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies

BioChannel - March 20, 2020

Biotechnology

CRISPR Base Editor Repairs Faulty Genes in Cystic Fibrosis Organoids

BioChannel - February 20, 2020

Biotechnology

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

BioChannel - January 23, 2020

Biotechnology

Leukemia’s Favorite Fix, Vitamin B6, Vulnerable to Pharmacological Blockade

BioChannel - January 13, 2020

Biotechnology

The Outlook for 2020 and Beyond

BioChannel - January 3, 2020

Biotechnology

NIH Director Backs Moratorium for Heritable Genome Editing

BioChannel - November 8, 2019

Biotechnology

Genome Editing Heads to Primetime

BioChannel - October 21, 2019

Biotechnology

Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna,...

BioChannel - August 23, 2019

Biotechnology

CRISPR Base Editing Gives Live Cell Computation an Upgrade

BioChannel - August 23, 2019

Biotechnology

Mammoth Biosciences Licenses 2 UC Patents for CRISPR-Based Diagnostic Platform

BioChannel - July 18, 2019

12 Page 1 of 2

Stay connected

Recent posts

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

BioChannel - April 3, 2020

ASCE/EMI awards Dan M. Frangopol 2020 Alfred M. Freudenthal Medal

BioChannel - April 3, 2020

Nanoneedle technology licensed for early detection of disease, biomarker discovery

BioChannel - April 2, 2020

Random article

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

ASCE/EMI awards Dan M. Frangopol 2020 Alfred M. Freudenthal Medal

Nanoneedle technology licensed for early detection of disease, biomarker discovery

Cytiva Picks Up Where GE Leaves Off after $21B Deal